top of page

Mwandishi:

Mhariri:

Imeboreshwa:

6 Juni 2026, 03:53:32

Management of Critical COVID-19 Disease

Management of Critical COVID-19 Disease
Management of Critical COVID-19 Disease
Management of Critical COVID-19 Disease
Management of Critical COVID-19 Disease

Management of Critical COVID-19 Disease


CRITICAL COVID-19 DISEASE

Includes:

  • Respiratory failure

  • Septic shock

  • Multi-organ dysfunction

May progress toSeptic shock


ICU ADMISSION REQUIRED


i. Airway & Ventilation

  • Intubate if airway not protected

  • Mechanical ventilation:

    • SpO₂ target > 90%

    • Tidal volume 4–8 mL/kg

    • Plateau pressure < 30 cmH₂O


ii. Oxygenation

  • High-flow oxygen → NIV → Mechanical ventilation

  • Awake or ventilated proning


iii. Steroids

Same as severe disease


iv. Anticoagulation

Same protocol as severe disease


v. Hemodynamic support

  • IV fluids for shock

  • Maintain MAP ≥ 65 mmHg

  • Vasopressors if needed


vi. Antibiotics

Broad spectrum therapy then culture-guided


vii. Organ support

  • Renal support (dialysis if needed)

  • Nutrition therapy

  • Stress ulcer prophylaxis

  • Physiotherapy


Investigational/Adjunct therapies

Used in some settings:

  • Remdesivir

  • Tocilizumab

  • Colchicine

(Used selectively depending on protocol and availability)


CORE PRINCIPLE OF COVID-19 MANAGEMENT

  • Mild → symptomatic care

  • Moderate → anti-inflammatory therapy

  • Severe → oxygen + steroids + anticoagulation

  • Critical → organ support + ICU care

Imeandikwa:

26 Mei 2026, 07:49:45

bottom of page